Literature DB >> 16631438

Clinical significance of homocysteine in elderly hospitalized patients.

José Juan Viña Rodríguez1, Francisco Santolaria, Antonio Martínez-Riera, Emilio González-Reimers, María José de la Vega Prieto, María Remedios Alemán Valls, Melchor Rodríguez Gaspar.   

Abstract

Serum homocysteine levels, which increase with age, are now recognized as a vascular risk factor and are related to the development of heart failure and dementia in the elderly. However, relatively low serum homocysteine levels have also been reported to be an adverse prognostic factor in dialysis patients. The objective of the study was to analyze the prevalence, clinical significance, and prognostic value of serum homocysteine levels in patients older than 65 years, admitted to a general internal medicine hospitalization unit. We studied 337 hospitalized patients, 184 males and 153 females, aged 77.2+/-0.4 years, whose admission was not determined by an acute vascular event. We recorded past vascular events and vascular risk factors. We determined the body mass index (weight in kilograms divided by the square of height in meters), and cholesterol, triglyceride, folate, vitamin B12, and homocysteine levels. We also studied 36 control subjects (18 males and 18 females) of similar age. After discharge, we assessed the survival status of 301 patients by telephone recall. Survival curves were plotted by the method of Kaplan and Meier. Median survival was 1186 days. The 15th (9.6 micromol/L) and 50th (14.4 micromol/L) percentiles, as the lowest and highest cut-off points, were empirically defined as those related to a shorter survival. Serum homocysteine concentration was significantly positively correlated with age and serum creatinine and albumin concentrations, and negatively correlated with serum cobalamin and folate concentrations. The average serum homocysteine concentration for the patients group, as a whole, was 16.5+/-0.5 micromol/L, not significantly different from the control group, but with a much greater dispersion, as patients with congestive heart failure or cognitive impairment had higher serum homocysteine concentrations, and patients with sepsis, leukocytosis, and hypoalbuminemia had lower concentrations. Malnutrition was associated both with abnormally high and low homocysteine concentrations, and abnormally low and abnormally high homocysteine concentrations were both associated with higher mortality. In conclusion, low homocysteine levels in elderly non-vitamin-supplemented hospitalized patients should not be interpreted as a protective factor in some individuals. Instead, it may be considered as an effect of an inflammatory-malnutrition process associated with a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631438     DOI: 10.1016/j.metabol.2005.12.009

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  The status of vitamins B6, B12, folate, and of homocysteine in geriatric home residents receiving laxatives or dietary fiber.

Authors:  B Sturtzel; A Dietrich; K-H Wagner; C Gisinger; I Elmadfa
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

2.  A simple and accurate HFCF-UF method for the analysis of homocysteine, cysteine, cysteinyl-glycine, and glutathione in human blood.

Authors:  Wei-Chong Dong; Jia-Liang Guo; Meng-Qiang Zhao; Xi-Kun Wu; Yi-Xuan Cui; Jing-Ying Feng; Chen-Xiao Zhang; Ye Jiang; Zhi-Qing Zhang
Journal:  Anal Bioanal Chem       Date:  2021-08-18       Impact factor: 4.142

3.  Blood Concentrations of Homocysteine and Methylmalonic Acid among Demented and Non-Demented Swedish Elderly with and without Home Care Services and Vitamin B(12) Prescriptions.

Authors:  Nils-Olof Hagnelius; Lars-Olof Wahlund; Jörn Schneede; Torbjörn K Nilsson
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-09-21

Review 4.  Dietary Regulation of Immunity.

Authors:  Aileen H Lee; Vishwa Deep Dixit
Journal:  Immunity       Date:  2020-09-15       Impact factor: 43.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.